Using purine auxotrophic strains of Escherichia coli with additional genetic lesions in the pathways of interconversion and salvage of purine compounds, we demonstrated the in vivo function of guanosine kinase and inosine kinase. Mutants with increased ability to utilize guanosine were isolated by plating cells on medium with guanosine as the sole purine source. These mutants had altered guanosine kinase activity and the mutations were mapped in the gene encoding guanosine kinase, gsk. Some of the mutants had acquired an additional genetic lesion in the purine de novo biosynthetic pathway, namely apurF, apurL or apurM mutation. A revised map location of the gsk gene is presented and the gene order established asproc-acrA-apt-adkgsk-purE.
Role of Guanosine Kinase in the Utilization of Guanosine for Nucleotide Synthesis in Escherichia COS
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Using purine auxotrophic strains of Escherichia coli with additional genetic lesions in the pathways of interconversion and salvage of purine compounds, we demonstrated the in vivo function of guanosine kinase and inosine kinase. Mutants with increased ability to utilize guanosine were isolated by plating cells on medium with guanosine as the sole purine source. These mutants had altered guanosine kinase activity and the mutations were mapped in the gene encoding guanosine kinase, gsk. Some of the mutants had acquired an additional genetic lesion in the purine de novo biosynthetic pathway, namely apurF, apurL or apurM mutation. A revised map location of the gsk gene is presented and the gene order established asproc-acrA-apt-adkgsk-purE.
I N T R O D U C T I O N
A number of purine sources can supply the requirement of purine auxotrophic strains of Escherichia coli. Among these compounds are purine ribonucleosides and deoxyribonucleosides. Adenosine, inosine and guanosine and the corresponding 2'-deoxy compounds can serve as the sole purine source (Nygaard, 1983) . The utilization of the purine deoxyribonucleosides is dependent upon the functioning of purine nucleoside phosphorylase, encoded by the deoD gene. Strains that are deoD cannot incorporate exogenous purine deoxyribonucleosides into DNA (Karlstrom, 1970) , nor will pur deoD strains utilize purine deoxyribonucleosides for growth (Hoffmeyer & Neuhard, 1971) .
Several enzymes are responsible for the conversion of purine ribonucleosides to the corresponding ribonucleoside 5'-monophosphates. Inosine, adenosine and guanosine can be phosphorolysed to the corresponding bases and ribose 1 -phosphate by purine nucleoside phosphorylase. The bases in turn may be phosphoribosylated to the nucleoside 5'-monophosphates by appropriate phosphoribosyltransferases. Also guanosine and inosine kinase activities have been identified and the gsk gene, encoding guanosine kinase, mapped in E. coli (Jochimsen et al., 1975) . Nucleotide synthesis from adenosine proceeds via phosphorolysis as above or through initial deamination to inosine, catalysed by adenosine deaminase (Hoffmeyer & Neuhard, 1971 ; Nygaard, 1983; Livshits, 1976) . A different pathway has been proposed for converting adenosine to AMP, involving cleavage of adenosine to adenine by an enzyme different from purine nucleoside phosphorylase (Livshits & Sukhodolets, 1973 a) . The physiological implications of this enzyme have not been solved, but the enzyme responsible is very likely adenosylhomocysteine nucleosidase. This enzyme has affinity towards adenosine in vitro (Jochimsen, 1979) . Relevant auxiliary pathways as well as the de novo purine pathway of E. coli are given in Fig. 1 . Detailed reviews of the metabolism of purine nucleotides have recently appeared (Nygaard, 1983 ; Neuhard & Nygaard, 1987) .
Abbrmiation : AIR, aminoimidazole ribonucleoside 5'-monophosphate.
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. -Jensen, 1985 ; HoveJensen el a f . , 1986). The individual de ~O O O reactions are indicated by the genes encoding the respective enzymes : purF, glutamine PRPP amidotransferase; purD, GAR synthase; purN, GAR formyltransferase; purL, FGAR amidotransferase; purM, .4IR synthase; purEK, AIR carboxylase; p u r e , SAICAR synthase ; purB, adenylosuccinate lyase ; purH, AICAR formyltransferase ; purA, adenylosuccinate synthase; guaB, IMP dehydrogenase; guaA, G M P synthetase. In E . cofi no gene has been assigned to the IMP cyclohydrolase. The broken arrow indicates the reactions leading from AIR to thiamin pyrophosphate (TPP, Newel1 & Tucker, 1968) . The auxiliary reactions are indicated by numbers: 1, guanosine kinase (encoded by gsk); 2, purine nucleoside phosphorylase (deoD); 3, G M P reductase (guaC) ; 4, adenine phosphoribosyltransferase (apt) ; 5 , hypoxanthine phosphoribosyltransferase (hpt); 6, guanine-xanthine phosphoribosyltransferase (gpt); 7 , xanthosine phosphorylase (xapA); 8, adenosine deaminase (add). The reactions leading from ATP to AICAR are part of the histidine biosynthetic pathway. The functioning of this pathway is inhibited by the presence of histidine. The xapA gene is not expressed unless xanthosine is given as carbon source. Only under these conditions will xanthosine serve as purine source.
Two potent nucleoside transport systems, encoded by the nupC and nupG genes, have been determined genetically in E. cofi (Munch-Petersen & Mygind, 1976; Hansen et al., 1987) . The two systems differ slightly in their specificities. Thus, the nupG-encoded system is responsible for uptake of all ribonucleosides and deoxyribonucleosides, whereas the nupC-encoded system takes up all ri bonucleosides and deoxyribonucleosides except guanosine and deoxyguanosine (MunchPetersen & Mygind, 1983) .
Purine ribonucleoside kinases have been only sparsely described in E. coli (Jochimsen et al., 1975) , Salmonella typhimurium (Hoffmeyer & Neuhard, 1971; Gots et al., 1977) or other organisms (Fink & Nygaard, 1978) . In this study, we have examined the physiological role of guanosine kinase (ATP : guanosine 5'-phosphotransferase, EC 2.7.1 .-), by analysing the functioning of the enzyme in uiuo. We further present a characterization of mutants with improved utilization of guanosine as a purine source. Among these mutants, we found some that had increased activity of guanosine kinase. Guanosine-utilizing mutants have been previously described. Two types of mutants were isolated in E. coli by Livshits & Sukhodolets (1973b) : one type was found among rifampin-resistant mutants; the other was isolated by using guanosine as the sole purine source, and the genetic lesion mapped close to the purE gene. Both in E. coli and in S . typhimurium guanosine-utilizing mutants with defective phosphoribosylpyrophosphate synthetase have been reported (Hove-Jensen & Nygaard, 1982; Jochimsen et al., 1985) .
METHODS
Bacterial strains. All the E. coli K 12 strains used and their genotypes are listed in Table 1 . Media, cell growth and the preparation of cell extracts. Growth medium was phosphate-buffered AB minimal medium (Clark & Maalse, 1967) . Broth medium contained, per litre: 10 g Bactotryptone (Difco), 5 g yeast extract (Difco), 5 g NaCI, 1 g glucose. Solid media were prepared by adding 1.5% (w/v) agar (Difco) to AB or broth ingredients. Growth rates were determined by growing 20 ml cultures in 200 ml flasks with aeration by shaking at 37 "C. Growth was followed as optical density (OD) at 436 nm in an Eppendorf 1 lOlM photometer. An ODa3, of 1.0 (1 cm light path) corresponds to approximately 3 x lo8 cells ml-I. Glucose or glycerol (0.2%) served as the carbon source. When necessary, amino acids were added to 40 mg 1-I. Purine bases were added to 15 mg I -I , ribonucleosides to 30 mg 1 -I . Nicotinic acid was added to 1 mg 1-I. Thiamin (1 mg 1-I) was added to all minimal media unless otherwise stated. Tetracycline was used at 5 mg 1 -I . Cultures for enzyme analysis were grown at 37 "C with aeration by air bubbling. At an of approximately 1 the cells were cooled and harvested by centrifugation. Following a wash in 0.9% saline, the cells were suspended in 50 mM-Tris/HCl, pH 7.8, at 50 times the original cell density. After homogenization by sonication and removal of debris by centrifugation, the cell extract was desalted by passage through a small column of Sephadex G25, equilibrated with 50 mM-Tris/HCl, Guanosine kinase assay. Specific activity is given as nmol min-' (mg protein)-*. Protein content was determined by the Lowry method, with bovine serum albumin as the standard. Guanosine kinase activity was determined by a modification of the procedure described by Jochimsen et al. (1975) . The assay contained, in a final volume of 0.1 ml: 70 mM-Tris/HCl, pH 7-8; 35 mM-KCl; 35 mM-MgC1,; 1 mM-ATP; 0.5 mM (18.5 GBq mol-I) [U-14C]guanosine; 10 mM-phosphoenolpyruvate; 1 pg pyruvate kinase; and guanosine kinase activity (0.2-1.0 nmol min-I). Samples were removed at appropriate intervals and processed as described by Jochimsen et al. (1 975) .
Incorporation of"'Y'1guanosine into nucleic acids. At an OD,,, of 0.05, cells growing exponentially at 37 "C were supplemented with 10 p~-( 4 0 GBq mol-I) [8-I4C] guanosine and allowed to incorporate radioactivity until an ODd3, of 1 was reached. Then the cells were treated with 0.5 M-trichloroacetic acid and the radioactivity incorporated into nucleic acids was determined as acid-insoluble material.
Determination of 5-aminoimidazole ribonucleoside 5'-monophosphate (AIR).
The procedure of Bratton & Marshall (1939) was employed. In this procedure AIR, excreted from the cells as the ribonucleoside, is converted to a coloured diazo compound, with an absorption maximum at 500 nm.
Ribonucleoside triphosphatepool determinations. Cells were grown in a Tris-buffered medium containing 0.3 mM-P, (Jensen et al., 1979) . After several generations of exponential growth, carrier-free 32P, (Forsergscenter Riser, Denmark) was added at 1.22 TBq mol-' . Following an additional two generations of growth, the nucleotides were extracted by addition of HCOOH to a final concentration of 0.33 M. Nucleotides were separated by twodimensional thin-layer chromatography as described by Neuhard et al. (1 965) .
Mutagenization. Cells growing exponentially in supplemented minimal medium were harvested, washed and resuspended in unsupplemented medium, placed under a UV lamp, irradiated to approximately 0.1 % survival and grown overnight in minimal medium for phenotypic expression. Alternatively, the cells were infected with bacteriophage Mucts62 by placing droplets of a phage lysate onto a lawn of recipient cells in soft agar. Cells from the infected area were cut out of the agar, inoculated in broth medium and grown overnight for phenotypic expression.
Transduction. Plcir lysates were prepared by the soft agar overlay technique and transduction was performed as described by Lennox (1955) . Genetic markers were scored as follows: the acrA marker was scored on broth plates supplemented with acriflavine (Nakamura et al., 1975) ; adk is a temperature-sensitive marker (Ray et al., 1970) ; apt was scored on plates with adenine serving as purine source (Jochimsen et al., 1975) . pH 7.8. E. coli K-12 strain W6 (Bachmann, 1972) penicillin counterselection (Jochimsen et al., 1975) * All the strains are F-strains, except ORF4/KL251, which is an F' strain, and AB2849 (F+).
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t Obtained through the Coli Genetic Stock Center (CGSC).
$ Nomenclature of TnIU insertions follows the rules of Chumley et al. (1979) .
St..uduction. Equal numbers o f exponentially growing donor and recipient cells in minimal medium were mixed for 1 h at 37°C and diluted samples plated on selective medium. Streptomycin (200mg 1-l) was used for coun terselection.
Isolation of a TnlO insertion near the gsk gene. A bacteriophage P1 lysate was grown on the pool of randomly inserted TnlO transposons [transposable genetic element coding for tetracycline resistance (TetR)] previously described (Hove-Jensen, 1983 ). This lysate was used to infect strain S0199 (purE) with subsequent selection for Pur+TetR. Among a number of independent TnlO insertions obtained and mapped, zbb-2419 : :TnlO (H0419) was used in this work.
Isolation of mutants able to utilize guanosine as sole purine source. The strain S0446 was submitted to UV irradiation or bacteriophage Mu treatment as described above. Following phenotypic expression, lo8 cells were plated on glucose minimal medium with guanosine as the sole source of purine. Colonies were purified on the same medium; pur+ and deoD+ revertants were discarded.
Chemicals. All chemicals were commercially available and used without further treatment. [U-'4C]Guanosine and [8-'"C]guanosine were obtained from Amersham. Phosphoenofpyruvate and pyruvate kinase were from Boehringer Mannheim.
R E S U L T S
In uivo euidence for guanosine and inosine kinase activities The guanine requirement of E. coligua strains can be fulfilled not only by guanine, but also by guanosine. This is also true if purine nucleoside phosphorylase (encoded by deoD) is nonfunctional. As shown in Table 2 , strain S0490 (guaA deoD) grows almost normally with guanosine serving as source of guanine nucleotides, and its purine ribonucleoside triphosphate pools are almost normal. These results indicate that a pathway different from that involving purine nucleoside phosphorylase for the conversion of guanosine to G M P exists.
To demonstrate inosine utilization, we used a strain defective in inosine 5'-monophosphate synthesis (Fig. l) , S0312 (purE deoD), which can be supplied by hypoxanthine or by inosine as shown in Table 2 . However, inosine only poorly fulfils the requirement. If, instead, a strain defective in inosine 5'-monophosphate synthesis and also defective in AMP synthesis (Fig. l) , S0405 (purB deoD) is used, inosine satisfies quite well the need for guanine nucleotides when adenine serves as adenine nucleotide source. Thus, there are only minor differences in the growth rate or in the pools of ATP and GTP, whether the strain is grown with hypoxanthine or inosine to supply the guanine nucleotides. In these experiments, histidine was added to prevent adenine from being converted to guanine nucleotides through the histidine pathway (Fig. 1) . The results clearly demonstrate that pathways different from phosphorolysis of guanosine and inosine exist. These pathways depend on guanosine and inosine kinase activities.
Guanosine transport
To determine whether the guanosine transport system (nupG) was a growth-limiting factor in the utilization of guanosine, we compared the growth of the two strains SO1098 (guaA deoD) and S01628 (guaA deoD nupG) . Although the transport of guanosine was reduced in the nupG strain t H 0 9 is a temperature-resistant derivative of H020 (Table 1) . Table 4 
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. Guanosine kinase activity and guanosine incorporation in guanosine-utilizing mutants
Guanosine kinase activity was determined at the temperature indicated by the procedure described in Methods. Incorporation of guanosine into acid-insoluble material was performed as described in Met hods. as compared to the nupG+ strain (data not shown), there was no difference in growth rate between the two strains, when the guanosine concentration was varied from 7 to 1 0 0~~.
Guanosine kinase activity [nmol min-I (mg protein)-']
-
Guanosine incorporation
Isolation and characterization of mutants with improved utilization ofguanosine jor nucleotide synthesis
The utilization of purine ribonucleosides is not very efficient by purE deoD strains of E. coli. Specifically, the utilization of guanosine is very poor. Besides guanosine kinase, the utilization of guanosine by purEdeoD strains requires the participation of yet another enzyme, GMP reductase (Fig. 1) . Although guanosine kinase and GMP reductase can be detected in extracts of purE deoD strains, growth does not occur with guanosine. Assuming that the limiting step under these conditions is the phosphorylation of guanosine, it should be possible to isolate mutants with increased guanosine kinase activity by plating mutagenizedpur deoD cells on medium with guanosine serving as sole purine source as described in Methods. From this selection, the following mutants were isolated: H01, H03, H04, H020 and S01172 ( Table 1 ). The growth rates of the guanosine-utilizing mutants supplemented with different purine sources were determined ( Table 3 ). The results indicate that (i) the growth of HOl, H 0 4 and H 0 9 is improved not only on guanosine, but also on guanine, a compound that is metabolized without the participation of guanosine kinase, and (ii) growth on inosine is also increased although not to the same extent as on guanosine for strains HOl and H04, H 0 9 and S01172 (Table 3) . Inosine is metabolized via guanosine kinase.
The mutants were assayed for guanosine kinase, and all had altered guanosine kinase activity (Table 4) . Although at 37 "C there was either no difference or only minor differences between the parent and the mutants, when the enzyme was assayed at 42 "C the mutants showed a 6-to * The episome was transferred from ORF4/KL251 as described in Methods, by selection for upr+ on plates with t The number of transductants examined is given in parenthesis.
$ The Upp phenotype was scored on plates containing 5-fluorouracil(2.5 mg 1-I). Cells that are upp are resistant, and thiamin adenine as the purine source.
whereas upp+ cells are sensitive to 5-fluorouracil.
22-fold increase in specific activity. We also determined the incorporation of guanosine into nucleic acids at 37 "C, and found that the mutants had a 6-to 14-fold increase in incorporation (Table 4) . From the enzyme and incorporation data we conclude that the mutants have alterations in the gene specifying guanosine kinase. These mutations result in enzymes that function more efficiently in uivo, and in vitro they appear more heat-stable.
Genetic mapping of' the mutations causing altered guanosine kinase activity
To demonstrate that the mutations causing the alterations in guanosine kinase mapped in the gsk gene we isolated a TnZO insertion (zbb-2419 : : TnZO) between gsk andpurE, which are closely linked markers (Jochimsen et al., 1975) . The zbb-2419 : :TnlO allele was then transduced into strain H 0 3 (purE gsk-3), resulting in a strain with the genotype purE gsk-3 zbb-2419 : : TnZO. The presence of an altered guanosine kinase was confirmed by assay. A P1 lysate was then grown on this purE gsk-3 zbb-2419 : :TnZO strain and used to transduce strain S0445
(purE deoD gsk-1) to tetracycline resistance. Of the 61 transductants analysed, 31 % were able to use guanosine for G M P synthesis, indicating acquisition of a functional gsk gene. Moreover, all these transductants were able to use guanosine as sole purine source, indicating acquisition of the altered guanosine kinase. This was confirmed by assay of the enzyme in some of the transductants. Identical results were obtained for the gsk-2 and gsk-9 alleles. We therefore conclude that the lesions causing the altered guanosine kinases are, indeed, alleles of the gsk gene.
Mutants with secondary blocks While working with the mutants described above, we noticed that the strains H01, H 0 4 and H 0 9 could not be transduced to Pur+ by P1 transduction, indicating that the mutants in some way had become double purine auxotrophs. This was confirmed by introducing the episome F254 (purE+) into the strains. The purine lesions of strains H01, H 0 4 and H 0 9 were characterized by identifying the purine pathway intermediates that the strains accumulated during purine starvation and by genetic mapping of the lesions. None of the mutants accumulated AIR as did the parental purE strain, suggesting mutations in genes specifying the purine enzymes catalysing the early steps of the pathway. All three strains accumulated phosphoribosyl pyrophosphate, but H 0 4 did so to a much greater extent than H 0 1 and H09, characteristic of purF strains (Jensen et al., 1979) . Strain H 0 1 accumulated formylglycinamide ribonucleoside 5'-monophosphate and H 0 9 formylglycinamidine ri bonucleoside 5'-monophosphate (cf. Fig. l) , determined by the procedure of Houlberg et al. (1983) . These results indicate that H 0 1 is defective in purL, H 0 4 in purF and H 0 9 in purM.
The secondary purine lesions in strains H01, H 0 4 and H 0 9 were mapped by cotransduction with appropriate markers as shown in Table 5 . The data indicate a location of thepur marker in strain H 0 1 close to nadB, consistent withpurL (experiment no. 1). In strain H 0 4 the purine Table 6 and previously published data (Jochimsen et al., 1975) . Arrowheads point towards the unselected markers.
marker was closely linked to aroC, indicative of purF (experiment no. 2, Table 5 ). Finally the secondarypur marker in strain H 0 9 was shown to bepurM. Strain H 0 9 required thiamin for growth (Fig. 1) . By selection in transduction for thiamin independence, recombinants that had lost the secondary pur lesion were obtained. The data given in Table 5 (experiment no. 3) revealed that the mutation is very closely linked with upp, as is purM. It appears that the selection of guanosine-utilizing mutants has given rise to double mutants H01 (purL gsk-lo), H04 (purFgsk-4), H09 (purMgsk-9), and also S01172 (prsgsk-2). The latter strain has been previously characterized with respect to the defective p hosp hori bosylpyrop hosp hate synt he tase, encoded by prs (Hove-Jensen & Nygaard, 1982; Hove-Jensen, 1983 ).
Genetic mapping of gsk While studying the genetics of the gsk mutants, we found that the gsk gene was incorrectly placed on the current linkage map (Jochimsen et al., 1975; Bachmann, 1983) . Although we confirmed the linkage of gsk and purE, we noticed that gsk was located counter-clockwise of purE rather than clockwise. The previous clockwise assignment was based on two-factor crosses and on complementation data using various F-episomes. We have performed a more detailed genetic analysis of the proC-purE region including the markers acrA, adk, apt and zbb-2419 : :TnlO. The results obtained from three-factor crosses are given in Table 6 and the gene order found is shown in Fig. 2 .
Guanosine can be converted to GMP by either of two pathways in E. coli : (i) phosphorolysis to guanine (and ribose 1-phosphate) followed by phosphoribosylation of the guanine moiety, or (ii) direct phosphorylation (Fig. 1) . Both pathways appear to operate in wild-type E. coli cells when guanosine is taken up from the culture medium and metabolized (Jensen, 1978) . It is not known by which pathway the guanosine nucleotides degraded inside the cells are salvaged. The various nucleotidases, most of which are ectoenzymes, degrade nucleoside monophosphates to the nucleosides. Recently an enzyme that degrades dGTP and GTP to deoxyguanosine and guanosine, respectively, has been purified and studied (Seto et al., 1988) . The physiological role of this enzyme is not known.
In the present study, we have investigated the guanosine kinase pathway. First it appears that the pathway is inefficient. Exogenous guanosine can be used when only GMP is needed, but cannot be used when there is an additional demand to supply AMP. The limiting process apparently is not guanosine transport. Rather the formation of GMP from guanosine most likely is growth limiting in purEdeoD strains, but this is not the case in guaA deoD strains. The difference between the two strains is that ATP is abundant in the guaA strain. In contrast to the purE strain, the de novo synthesis of AMP is not impaired in the guaA strain. ATP is not only required by guanosine kinase for activity, but high levels stimulate the enzyme. As a consequence, only small amounts of GMP are formed in thepurE deoD strain and conversion to AMP does not occur via the GMP reductase pathway (Fig. l) , because the induction of this conversion pathway requires a high level of guanine nucleotides. This appears to explain why purE deoD strains do not utilize guanosine as the sole purine source. Another consideration is that ATP stimulates the synthesis of GMP and also inhibits the conversion of GMP to AMP. Thus, the increased synthesis of GMP inguaA deoD strains solely furnishes the cell's demand for guanine nucleotides. The fact that E. coZi possesses guanosine kinase activity probably reflects that guanosine salvage occurs and that this only can be a supplement to the overall nucleotide synthesis. All the guanosine-utilizing mutants isolated showed altered guanosine kinase activity (Table 4) . Preliminary kinetic investigations of guanosine kinase in cell-free extracts from the gsk mutants indicate that the kinetic properties are altered, the apparent K , for guanosine being lowered. Besides the gsk mutation we identified mutations that caused deficiencies in one of the early enzymes of the purine biosynthetic pathway, catalysing the steps before the purE-encoded reaction. If we consider the synthesis of phosphoribosylpyrophosphate as an early step in purine biosynthesis (Fig. l) , strain S01172 belongs to this group of double mutants (Table 4 ). An exception to this is strain H03. In this mutant, we found no evidence for additional mutations. However, the growth of this strain on guanosine is reduced compared to the double mutants (Table 3 ). The additional defects in the de novo purine pathway are apparently advantageous.
When purE strains are starved for purines they accumulate AIR. Because this compound in fact is a purine analogue, it appears to inhibit guanosine metabolism. The guanosine-utilizing mutants isolated by Livshits & Sukhodolets (1973b) were obtained in a purD deoD genetic background. This proves that accumulation of AIR during purine starvation is not a prerequisite for the isolation of guanosine-utilizing mutants. Rather, AIR further stresses the cells and gives rise to mutants synthesizing more efficient enzymes. As can be seen in Table 3 the guanosine-utilizing mutants HOl, H 0 4 and H 0 9 (with additional defects in a pur gene) also grew better on guanine than did H03, which harbours a gsk mutation alone. This might indicate
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that the GMP reductase pathway is inhibited by AIR which accumulates in purE strains when starved for purines. B. Bachmann, K. Hammer, H. Nakamura and B. Mygind are acknowledged for generously providing bacterial strains and J. Steno Christensen for excellent technical assistance.
